Skip to main content
OpenTrials
Completed

NCT Number: NCT04507230

COVID-19 Associated Coagulopathy in Egypt

Coagulopathy is one of the most significant prognostic factors in patients with COVID-19 and is associated with increased mortality and admission to critical care. Most commonly observed coagulopathy in patients hospitalized with COVID-19 (COVID-19-associated coagulopathy) is characterized by increased D-dimer and fibrinogen levels. 71% of patients who did not survive hospitalization reported to have developed disseminated intravascular coagulation (DIC) compared to 0.6% of survivors.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Coagulopathy COVID-19 Cardiovascular Diseases Coronaviridae Infections Coronavirus Infections Hematologic Diseases Hemic and Lymphatic Diseases Hemorrhagic Disorders Hemostatic Disorders Infections Lung Diseases Nidovirales Infections Pneumonia Pneumonia, Viral RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Thrombophilia Vascular Diseases Virus Diseases

Sex eligibility

All sexes

Study type

Observational

Primary location

Assiut University Hospitals

Asyut, 71515, Egypt

About this study

studying the detailed coagulation screen and second line coagulation parameters including both thrombophilia screen and other acute phase coagulation factors.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients with COVID 19 positive by RT- PCR

Exclusion criteria

  • no exclusions

Treatment and study plan

Primary outcomes

  1. Coagulation screen

    Time frame: 1 month

    Full coagulation screen

  2. Thrombophilia screen

    Time frame: 1 month

    Full thrombophilia screen

  3. VWF, FVIII

    Time frame: 1 month

    VWFAg, FVIII

Sponsors and collaborators

Lead sponsor

Assiut University

Other

Registry information

Official study title

Assessment of COVID-19 Associated Coagulopathy and Hypercoagulable State in Upper Egypt

Important dates

Study start
2020
Primary completion
2020
Study completion
2020
First posted
Aug 11, 2020
Registry last updated
Mar 11, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.